Michael Harty (Clare, Independent) | Oireachtas source

The purpose of the meeting is to meet Medical Council representatives to get an insight into and examine workforce planning in the health sector. We will hold two sessions on this topic, the first with the Medical Council and the second at 11.30 a.m. with the Irish Hospital Consultants Association, IHCA. On behalf of the committee, I welcome Mr. Bill Prasifka, chief executive officer, CEO, of the Medical Council; Dr. Rita Doyle, president; and Ms Janet O'Farrell, research manager.

I draw the attention of witnesses to the fact that by virtue of section 17(2)(l) of the Defamation Act 2009, they are protected by absolute privilege in respect of their evidence to the committee. However, if they are directed by the committee to cease giving evidence on a particular matter and they continue to so do, they are entitled thereafter only to a qualified privilege in respect of their evidence. They are directed that only evidence connected with the subject matter of these proceedings is to be given and they are asked to respect the parliamentary practice to the effect that, where possible, they should not criticise or make charges against any person, persons or entity by name or in such a way as to make him, her or it identifiable. I advise witnesses that any opening statements they make may be published on the committee's website after the meeting.

Members are reminded of the long-standing parliamentary practice to the effect that they should not comment on, criticise or make charges against a person outside the House or an official either by name or in such a way as to make him or her identifiable.

I invite Dr. Rita Doyle to make her opening statement.